Anti-cancer Effects of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside(AICAR) on Triple-negative Breast Cancer (TNBC) Cells: MitochondrialModulation as an Underlying Mechanism

Versha Tripathi(Devi Ahilya Vishwavidyalaya), Hamendra Singh Parmar(Devi Ahilya Vishwavidyalaya), Janesh Kumar(National Institutes of Health), Pooja Jaiswal(Galgotias University), Anshul Assaiya(National Centre for Cell Science)
Current Cancer Drug Targets
February 9, 2022
Cited by 11


Related Papers